Study on the Mechanism of SNX8 Regulating the Progression and Prognosis of Hepatocellular Carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500113544

Enrollment

Unknown

Registered

2025-12-01

Start date

2025-12-08

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Case group:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Hepatocellular carcinoma is accurately diagnosed; 2.Meet the age requirement; 3.Obtain complete clinicopathological and follow-up data; 4.Surgical resection is the main method; 5.Willing to sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Perioperative death; 2.Undergo palliative surgery; 3.Chemotherapy drug treatment has been received; 4.Combined with other cancers;

Design outcomes

Primary

Measure	Time frame
Sorting Nexin 8;	—

Countries

China

Contacts

Public ContactBin Zhou

The Second Affiliated Hospital of Wenzhou Medical University

pzhoubin@126.com+86 577 85676711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026